BELLICUM PHARMACEUTICALS INC's ticker is BLCM and the CUSIP is 079481107. A total of 91 filers reported holding BELLICUM PHARMACEUTICALS INC in Q4 2017. The put-call ratio across all filers is 1.40 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2019 | $2,000 | 0.0% | 500 | -28.6% | 0.00% | 0.0% |
Q4 2018 | $2,000 | 0.0% | 700 | +133.3% | 0.00% | 0.0% |
Q3 2018 | $2,000 | -50.0% | 300 | -40.0% | 0.00% | -50.0% |
Q2 2018 | $4,000 | +33.3% | 500 | +25.0% | 0.00% | +100.0% |
Q1 2018 | $3,000 | -25.0% | 400 | -20.0% | 0.00% | -50.0% |
Q4 2017 | $4,000 | -42.9% | 500 | -16.7% | 0.00% | -33.3% |
Q3 2017 | $7,000 | +16.7% | 600 | +20.0% | 0.00% | 0.0% |
Q2 2017 | $6,000 | -14.3% | 500 | -16.7% | 0.00% | -25.0% |
Q1 2017 | $7,000 | +600.0% | 600 | +500.0% | 0.00% | +300.0% |
Q4 2016 | $1,000 | – | 100 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Avoro Capital Advisors LLC | 220,000 | $5,069,000 | 3.43% |
Perceptive Advisors | 1,046,402 | $24,109,000 | 2.02% |
Redmile Group, LLC | 860,809 | $17,269,000 | 1.88% |
Baker Brothers Advisors | 4,283,732 | $98,697,000 | 1.01% |
RA Capital Management | 1,026,402 | $9,337,000 | 1.00% |
Ghost Tree Capital, LLC | 75,000 | $1,728,000 | 0.83% |
ACUTA CAPITAL PARTNERS, LLC | 45,750 | $1,054,000 | 0.71% |
GREAT POINT PARTNERS LLC | 50,000 | $1,152,000 | 0.55% |
EMERALD MUTUAL FUND ADVISERS TRUST | 167,210 | $3,853,000 | 0.33% |
EMERALD ADVISERS, LLC | 198,202 | $4,567,000 | 0.24% |